USPH Earnings

USPH reported its earnings on 2026-02-25, showcasing a revenue of against an estimate of 200.03M, resulting in a 0% surprise. The EPS was 0, surpassing the expected 0.67 by 0%. The stock experienced a -2.86% price change on the earnings day and a 0% change over the next five days, reflecting market reactions to the results.

Following USPH's earnings announcement on 2026-02-25, the stock price moved by -2.86% on the day of the release. Over the subsequent five days, it saw a 0% change. Historically, USPH's stock price tends to shift by an average of 0.96% in the 10 days leading up to earnings and 0.33% in the 10 days following, providing insight into potential market.

For 2026/Q1, analysts estimate USPH's annual revenue to reach 197.21M, while the EPS is projected at 0.56. These estimates reflect recent revisions, with revenue estimates unchanged by 0% and EPS estimates unchanged by 0% over the past three months, indicating analyst expectation in the company's performance.

The correlation between USPH's stock price and earnings forecast revisions shows that positive revisions in revenue or EPS often strengthen the stock's fundamentals. Over the past three months, revenue estimates for FY2025 were unchanged by 0%, while EPS estimates moved unchanged by 0%. This trend suggests that price dips could present buying opportunities for investors.

Based on historical trends, USPH's stock price typically moves by 0.96% in the 10 days before its earnings and 0.33% in the 10 days after. For the upcoming 2026/Q1 earnings, analysts expect an EPS of 0.56 and revenue of 197.21M.

The earnings call showed strong financial performance with increased revenues, margins, and EBITDA. The Q&A highlighted positive growth prospects, efficient cost management, and strategic acquisitions. Despite some concerns about wage inflation and unclear details on hospital rates, the company's optimistic guidance, improved margins, and strategic initiatives like AI-driven operations and acquisitions suggest a positive outlook. Given the company's market cap, the stock is likely to see a positive movement of 2% to 8% over the next two weeks.